Human Her2 & ErbB3 Protein, Fc Tag&Fc Tag (MALS verified)

AIDD‑Ready
1/6
+3 View all
Product Number/Spec
Price
Availability
Menge
HE2-H5254-100ug
$410.00
In Stock - Delivery in 1-2 business days
HE2-H5254-1mg (500ug X 2)
$2,680.00
In Stock - Delivery in 2 weeks
HE2-H5254
Product Amount :
$ 0
0
Add to Cart
New Product Suggestion Request Quote
Contact Us
Contact Us
Product Amount:
$ 0
0
Add to Cart
  • Product Details
  • Data Display
  • Reviews & Citations
  • Important Statement
  • Resources
Synonyms

Her2 & ErbB3, HER2 & HER3

Source

Human Her2 & ErbB3 Protein, Fc Tag&Fc Tag (HE2-H5254) is expressed from human 293 cells (HEK293). It contains AA Thr 23 - Thr 652 & Ser 20 - Thr 643 (Accession # P04626 & P21860).

Predicted N-terminus: Thr 23 & Ser 20

Molecular Characterization

Human Her2 & ErbB3 Protein, Fc Tag&Fc Tag, produced by co-expression of HER2 and ErbB3, has a calculated MW of 95.9 kDa (HER2) and 94.9 kDa (ErbB3). Subunit HER2 is fused with a human IgG1 Fc fragment at the C-terminus and subunit ErbB3 is fused with a human IgG1 Fc fragment at the C-terminus. The protein migrates as 110-130 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin

Less than 1.0 EU per μg by the LAL method / rFC method.

Purity

>90% as determined by SDS-PAGE.

Formulation

Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5 with trehalose as protectant.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Shipping and Storage

This product is shipped at ambient temperature.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.

Background Introduction

The Human Epidermal Growth Factor Receptor 2 (HER2) and HER3 form a potent pro-oncogenic heterocomplex upon binding of growth factor neuregulin-1β (NRG1β). The HER2/HER3 extracellular dimer dynamics likely have important implications for modulating receptor activity.